Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Investor's Business DailyNovavax will receive as much as $1.2 billion as part of a Covid vaccine licensing deal with Sanofi.
The post Biotech Rockets 125% On Sanofi Covid Vaccine Agreement appeared first on Investor's Business Daily.